Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 161

The DOI matches its Crossref record.

Adult and Pediatric Medulloblastomas Are Genetically Distinct and Require Different Algorithms for Molecular Risk Stratification

Korshunov, Andrey, Remke, Marc, Werft, Wiebke, Benner, Axel, Ryzhova, Marina, Witt, Hendrik, Sturm, Dominik, Wittmann, Andrea, Schöttler, Anna, Felsberg, Jörg, Reifenberger, Guido, Rutkowski, Stefan, Scheurlen, Wolfram, Kulozik, Andreas E., von Deimling, Andreas, Lichter, Peter, Pfister, Stefan M. · 2010 · Journal of Clinical Oncology

Abstract

Purpose: Medulloblastoma (MB) is the most common malignant brain tumor in children, whereas it rarely presents in adults. We aimed to identify genetic aberrations in 146 adult MBs to evaluate age-dependent differences in tumor biology and adapt age-specific risk stratification models. Methods: As a screening set, we studied a cohort of 34 adult MBs by using array-based comparative genomic hybridization comparing molecular results with clinical data. DNA copy number aberrations identified as possible prognostic markers were validated in an independent cohort of 112 adult patients with MB by fluorescent in situ hybridization analysis. Results were compared with the data obtained from 404 pediatric patients with MB. Results: CDK6 amplification, 10q loss, and 17q gain are the most powerful prognostic markers in adult MB. Whereas MYC/MYCN oncogene amplifications had a high prognostic value in pediatric MB, these aberrations were rarely observed in adult tumors. Surprisingly, adult MBs with 6q deletion and nuclear β-catenin activation did not share the excellent prognosis with their pediatric counterparts. Conclusion: Adult MB is distinct from pediatric MB in terms of genomic aberrations and their impact on clinical outcomes. Therefore, adult MBs require age-specific risk stratification models. We propose a molecular staging system involving three distinct risk groups based on DNA copy number status of 10q and 17q.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1200/jco.2009.25.7121

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 161

Metadata

Authors
Korshunov, A., Remke, M., Werft, W., Benner, A., Ryzhova, M., Witt, H., Sturm, D., Wittmann, A., Schöttler, A., Felsberg, J., Reifenberger, G., Rutkowski, S., Scheurlen, W., Kulozik, A. E., von Deimling, A., Lichter, P., & Pfister, S. M.
Venue
Journal of Clinical Oncology
Published
2010-06-20
Volume
28
Issue
18
Pages
3054-3060
ISSN
  • 0732-183X (ISSN-L)
  • 1527-7755
OpenAlex
W2064443826
Cited by
161
References
0
FWCI
8.29
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Adult and Pediatric Medulloblastomas Are Genetically Distinct and Require Different Algorithms for Molecular Risk Stratification. https://app.cochat.ai/papers/10.1200/jco.2009.25.7121
The paper
Korshunov, A., Remke, M., Werft, W., Benner, A., Ryzhova, M., Witt, H., Sturm, D., Wittmann, A., Schöttler, A., Felsberg, J., Reifenberger, G., Rutkowski, S., Scheurlen, W., Kulozik, A. E., von Deimling, A., Lichter, P., & Pfister, S. M. (2010). Adult and Pediatric Medulloblastomas Are Genetically Distinct and Require Different Algorithms for Molecular Risk Stratification. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2009.25.7121

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.